73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre
Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks
Researchers identify new gene mutation in familial thyroid cancers

Researchers identify new gene mutation in familial thyroid cancers

by Pennsylvania State UniversityCredit: CC0 Public DomainResearchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer. Dr. Darri

Researchers identify new gene mutation in familial thyroid cancers

by Pennsylvania State UniversityCredit: CC0 Public DomainResearchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer. Dr. Darri
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
New reports examine COVID's radiotherapy interruption implications

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur
New tools to manage rare eye cancer

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e
Cell competition may explain cancer relapses, research suggests

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy
Researchers discover method to 'turn off' mutated melanoma

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f
Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl
Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti